Athena Countouriotis
CIK: 0001571469
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 16, 2026IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectDeferred Restricted Stock Unit
90.3K shares- - Jun 2, 2026BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct7.5K shares- - May 19, 2026PASG
Passage BIO, Inc.
Award(A)DirectDirector Stock Option (right to buy)
10.5K shares- - Jun 13, 2025IOVA
IOVANCE BIOTHERAPEUTICS, INC.
Award(A)DirectDeferred Restricted Stock Unit
67.5K shares- - May 28, 2025PASG
Passage BIO, Inc.
Award(A)DirectDirector Stock Option (right to buy)
201.9K shares- - May 20, 2025BMRN
BIOMARIN PHARMACEUTICAL INC
Award(A)Direct6.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 16, 2026 |  IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Deferred Restricted Stock Unit | 90,316 | - | - | Direct |
| Jun 2, 2026 |  BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 7,490 | - | $0 | Direct |
| May 19, 2026 |  PASG Passage BIO, Inc. | Award(A) Director Stock Option (right to buy) | 10,539 | - | - | Direct |
| Jun 13, 2025 | IOVA IOVANCE BIOTHERAPEUTICS, INC. | Award(A) Deferred Restricted Stock Unit | 67,546 | - | - | Direct |
| May 28, 2025 | PASG Passage BIO, Inc. | Award(A) Director Stock Option (right to buy) | 201,857 | - | - | Direct |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | Award(A) | 6,650 | - | - | Direct |
1-6 of 6 transactions
About Countouriotis Athena
Countouriotis Athena (SEC CIK 0001571469) files insider reports with the SEC as Director of IOVANCE BIOTHERAPEUTICS, INC. (IOVA), Director of BIOMARIN PHARMACEUTICAL INC (BMRN) and Director of Passage BIO, Inc. (PASG).
Signal8 holds 6 ownership filings by Countouriotis Athena, all Form 4s, filed between May 22, 2025 and Jun 18, 2026. Those filings report 6 transactions, from May 20, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Countouriotis Athena's filings is in SAN RAFAEL, CA.
Recent filings by Countouriotis Athena
- Jun 16, 2026: Grant or award of IOVA derivative securities (Form 4, code A).
- Jun 2, 2026: Grant or award of BMRN shares (Form 4, code A).
- May 19, 2026: Grant or award of PASG derivative securities (Form 4, code A).
- Jun 13, 2025: Grant or award of IOVA derivative securities (Form 4, code A).
- May 28, 2025: Grant or award of PASG derivative securities (Form 4, code A).
Other insiders filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
- Berkowitz Noah, Chief Medical Officer
- Vogt Frederick G, Interim CEO & General Counsel
- BILINSKY IGOR, Chief Operating Officer
- Puri Raj K., Chief Regulatory Officer
- Kirby Daniel Gordon, Chief Commercial Officer
- Roche Corleen M., Chief Financial Officer